MANNKIND CORP (MNKD) Stock Fundamental Analysis

NASDAQ:MNKD • US56400P7069

3.035 USD
-0.24 (-7.47%)
At close: Mar 2, 2026
3.0298 USD
-0.01 (-0.17%)
After Hours: 3/2/2026, 4:10:28 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to MNKD. MNKD was compared to 520 industry peers in the Biotechnology industry. MNKD has a medium profitability rating, but doesn't score so well on its financial health evaluation. MNKD is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • MNKD had positive earnings in the past year.
  • MNKD had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: MNKD reported negative net income in multiple years.
  • The reported operating cash flow has been mixed in the past 5 years: MNKD reported negative operating cash flow in multiple years.
MNKD Yearly Net Income VS EBIT VS OCF VS FCFMNKD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M -100M

1.2 Ratios

  • MNKD has a Return On Assets of 0.85%. This is amongst the best in the industry. MNKD outperforms 87.88% of its industry peers.
  • MNKD has a better Return On Invested Capital (7.96%) than 93.27% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for MNKD is significantly below the industry average of 17.87%.
Industry RankSector Rank
ROA 0.85%
ROE N/A
ROIC 7.96%
ROA(3y)1.74%
ROA(5y)-9.91%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)10.85%
ROIC(5y)N/A
MNKD Yearly ROA, ROE, ROICMNKD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 100 -100 -150

1.3 Margins

  • MNKD has a better Profit Margin (1.92%) than 88.08% of its industry peers.
  • MNKD's Operating Margin of 16.59% is amongst the best of the industry. MNKD outperforms 93.08% of its industry peers.
  • With an excellent Gross Margin value of 77.80%, MNKD belongs to the best of the industry, outperforming 84.62% of the companies in the same industry.
  • In the last couple of years the Gross Margin of MNKD has grown nicely.
Industry RankSector Rank
OM 16.59%
PM (TTM) 1.92%
GM 77.8%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y20.37%
GM growth 5Y4.31%
MNKD Yearly Profit, Operating, Gross MarginsMNKD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200 -400 -600 -800 -1K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so MNKD is still creating some value.
  • The number of shares outstanding for MNKD has been increased compared to 1 year ago.
  • The number of shares outstanding for MNKD has been increased compared to 5 years ago.
  • The debt/assets ratio for MNKD is higher compared to a year ago.
MNKD Yearly Shares OutstandingMNKD Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
MNKD Yearly Total Debt VS Total AssetsMNKD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

2.2 Solvency

  • Based on the Altman-Z score of -4.07, we must say that MNKD is in the distress zone and has some risk of bankruptcy.
  • MNKD has a Altman-Z score of -4.07. This is comparable to the rest of the industry: MNKD outperforms 42.50% of its industry peers.
  • The Debt to FCF ratio of MNKD is 44.51, which is on the high side as it means it would take MNKD, 44.51 years of fcf income to pay off all of its debts.
  • MNKD's Debt to FCF ratio of 44.51 is amongst the best of the industry. MNKD outperforms 89.81% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 44.51
Altman-Z -4.07
ROIC/WACC0.98
WACC8.09%
MNKD Yearly LT Debt VS Equity VS FCFMNKD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M

2.3 Liquidity

  • A Current Ratio of 1.70 indicates that MNKD should not have too much problems paying its short term obligations.
  • The Current ratio of MNKD (1.70) is worse than 79.04% of its industry peers.
  • A Quick Ratio of 1.50 indicates that MNKD should not have too much problems paying its short term obligations.
  • MNKD's Quick ratio of 1.50 is on the low side compared to the rest of the industry. MNKD is outperformed by 80.58% of its industry peers.
Industry RankSector Rank
Current Ratio 1.7
Quick Ratio 1.5
MNKD Yearly Current Assets VS Current LiabilitesMNKD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • MNKD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -28.75%.
  • MNKD shows a strong growth in Revenue. In the last year, the Revenue has grown by 22.23%.
  • Measured over the past years, MNKD shows a very strong growth in Revenue. The Revenue has been growing by 39.91% on average per year.
EPS 1Y (TTM)-28.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-266.67%
Revenue 1Y (TTM)22.23%
Revenue growth 3Y51.78%
Revenue growth 5Y39.91%
Sales Q2Q%45.83%

3.2 Future

  • MNKD is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 74.72% yearly.
  • The Revenue is expected to grow by 19.14% on average over the next years. This is quite good.
EPS Next Y53.11%
EPS Next 2Y103.97%
EPS Next 3Y102.64%
EPS Next 5Y74.72%
Revenue Next Year25.53%
Revenue Next 2Y19.69%
Revenue Next 3Y18.6%
Revenue Next 5Y19.14%

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
MNKD Yearly Revenue VS EstimatesMNKD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 200M 400M 600M 800M 1B
MNKD Yearly EPS VS EstimatesMNKD Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 -0.5 -1 -1.5

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • MNKD is valuated quite expensively with a Price/Earnings ratio of 50.58.
  • Based on the Price/Earnings ratio, MNKD is valued cheaper than 89.81% of the companies in the same industry.
  • MNKD's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.07.
  • Based on the Price/Forward Earnings ratio of 34.78, the valuation of MNKD can be described as expensive.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of MNKD indicates a rather cheap valuation: MNKD is cheaper than 91.15% of the companies listed in the same industry.
  • MNKD is valuated rather expensively when we compare the Price/Forward Earnings ratio to 28.05, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 50.58
Fwd PE 34.78
MNKD Price Earnings VS Forward Price EarningsMNKD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • MNKD's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. MNKD is cheaper than 93.85% of the companies in the same industry.
  • MNKD's Price/Free Cash Flow ratio is rather cheap when compared to the industry. MNKD is cheaper than 92.31% of the companies in the same industry.
Industry RankSector Rank
P/FCF 68.08
EV/EBITDA 18.7
MNKD Per share dataMNKD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 -1

4.3 Compensation for Growth

  • MNKD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of MNKD may justify a higher PE ratio.
  • A more expensive valuation may be justified as MNKD's earnings are expected to grow with 102.64% in the coming years.
PEG (NY)0.95
PEG (5Y)N/A
EPS Next 2Y103.97%
EPS Next 3Y102.64%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for MNKD!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MANNKIND CORP

NASDAQ:MNKD (3/2/2026, 4:10:28 PM)

After market: 3.0298 -0.01 (-0.17%)

3.035

-0.24 (-7.47%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-26
Earnings (Next)05-06
Inst Owners57.07%
Inst Owner Change3.48%
Ins Owners1.59%
Ins Owner Change1%
Market Cap931.96M
Revenue(TTM)348.97M
Net Income(TTM)6.70M
Analysts85.33
Price Target9.8 (222.9%)
Short Float %8.7%
Short Ratio7.22
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-116.48%
Min EPS beat(2)-439.47%
Max EPS beat(2)206.52%
EPS beat(4)1
Avg EPS beat(4)-85.96%
Min EPS beat(4)-439.47%
Max EPS beat(4)206.52%
EPS beat(8)2
Avg EPS beat(8)-74.12%
EPS beat(12)5
Avg EPS beat(12)-38.6%
EPS beat(16)6
Avg EPS beat(16)-28.6%
Revenue beat(2)2
Avg Revenue beat(2)6.39%
Min Revenue beat(2)0.33%
Max Revenue beat(2)12.46%
Revenue beat(4)3
Avg Revenue beat(4)2.29%
Min Revenue beat(4)-4.55%
Max Revenue beat(4)12.46%
Revenue beat(8)6
Avg Revenue beat(8)2.33%
Revenue beat(12)9
Avg Revenue beat(12)3.51%
Revenue beat(16)12
Avg Revenue beat(16)6.12%
PT rev (1m)0%
PT rev (3m)6.05%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.05%
EPS NY rev (1m)0%
EPS NY rev (3m)-17.43%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.17%
Revenue NY rev (1m)-0.09%
Revenue NY rev (3m)5.67%
Valuation
Industry RankSector Rank
PE 50.58
Fwd PE 34.78
P/S 2.67
P/FCF 68.08
P/OCF 51.05
P/B N/A
P/tB N/A
EV/EBITDA 18.7
EPS(TTM)0.06
EY1.98%
EPS(NY)0.09
Fwd EY2.88%
FCF(TTM)0.04
FCFY1.47%
OCF(TTM)0.06
OCFY1.96%
SpS1.14
BVpS-0.17
TBVpS-1.44
PEG (NY)0.95
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 0.85%
ROE N/A
ROCE 9.32%
ROIC 7.96%
ROICexc 10.76%
ROICexgc 55.79%
OM 16.59%
PM (TTM) 1.92%
GM 77.8%
FCFM 3.92%
ROA(3y)1.74%
ROA(5y)-9.91%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)10.85%
ROIC(5y)N/A
ROICexc(3y)28.62%
ROICexc(5y)N/A
ROICexgc(3y)44.91%
ROICexgc(5y)N/A
ROCE(3y)12.18%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y20.37%
GM growth 5Y4.31%
F-Score5
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 44.51
Debt/EBITDA 8.33
Cap/Depr 37.17%
Cap/Sales 1.31%
Interest Coverage 3.93
Cash Conversion 26.02%
Profit Quality 204.41%
Current Ratio 1.7
Quick Ratio 1.5
Altman-Z -4.07
F-Score5
WACC8.09%
ROIC/WACC0.98
Cap/Depr(3y)368.18%
Cap/Depr(5y)300.07%
Cap/Sales(3y)8.68%
Cap/Sales(5y)9.77%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-28.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-266.67%
EPS Next Y53.11%
EPS Next 2Y103.97%
EPS Next 3Y102.64%
EPS Next 5Y74.72%
Revenue 1Y (TTM)22.23%
Revenue growth 3Y51.78%
Revenue growth 5Y39.91%
Sales Q2Q%45.83%
Revenue Next Year25.53%
Revenue Next 2Y19.69%
Revenue Next 3Y18.6%
Revenue Next 5Y19.14%
EBIT growth 1Y-18.59%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-58.29%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-57.06%
OCF growth 3YN/A
OCF growth 5YN/A

MANNKIND CORP / MNKD FAQ

What is the fundamental rating for MNKD stock?

ChartMill assigns a fundamental rating of 5 / 10 to MNKD.


Can you provide the valuation status for MANNKIND CORP?

ChartMill assigns a valuation rating of 6 / 10 to MANNKIND CORP (MNKD). This can be considered as Fairly Valued.


Can you provide the profitability details for MANNKIND CORP?

MANNKIND CORP (MNKD) has a profitability rating of 6 / 10.


What are the PE and PB ratios of MANNKIND CORP (MNKD) stock?

The Price/Earnings (PE) ratio for MANNKIND CORP (MNKD) is 50.58 and the Price/Book (PB) ratio is -18.27.